Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity?
- PMID: 15583604
- DOI: 10.1016/j.jaad.2004.06.009
Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity?
Abstract
Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) is a severe variant of pityriasis lichenoides et varioliformis acuta (PLEVA). PLEVA patients only very rarely have systemic signs; the cutaneous lesions are usually asymptomatic, but may be pruritic and may heal with scarring. FUMHD often starts out as classic PLEVA, but goes on to develop widespread ulceronecrotic lesions and is associated with a high mortality rate. Whether Pityriasis lichenoides chronica (PLC) and PLEVA form a spectrum rather than single entities of clonal lymphoproliferative diseases has been discussed. Recently, it has been proposed that FUMHD, too, is a clonal lymphoproliferative disorder. Here, we report two cases of FUMHD with monoclonal T-cell population, as detected by Southern blot analysis. We propose that clonal FUMHD represents a cutaneous T-cell lymphoma entity.
Similar articles
-
Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.Acta Derm Venereol. 2008;88(4):350-5. doi: 10.2340/00015555-0441. Acta Derm Venereol. 2008. PMID: 18709304 Review.
-
Febrile ulceronecrotic Mucha-Habermann disease with extensive skin necrosis in intertriginous areas.Eur J Dermatol. 2003 Sep-Oct;13(5):493-6. Eur J Dermatol. 2003. PMID: 14693498 Review.
-
Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica.Arch Dermatol. 2001 Mar;137(3):305-8. Arch Dermatol. 2001. PMID: 11255329
-
Febrile ulceronecrotic Mucha-Habermann disease in a 34-month-old boy: a case report and review of the literature.Pediatr Dermatol. 2012 Jan-Feb;29(1):53-8. doi: 10.1111/j.1525-1470.2011.01531.x. Epub 2011 Sep 9. Pediatr Dermatol. 2012. PMID: 21906156 Review.
-
Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha.Br J Dermatol. 2005 Apr;152(4):794-9. doi: 10.1111/j.1365-2133.2005.06485.x. Br J Dermatol. 2005. PMID: 15840118 Review.
Cited by
-
Febrile Ulceronecrotic Mucha-Habermann Disease: A Case Report and a Systematic Review.Case Rep Dermatol. 2022 Jun 27;14(2):169-177. doi: 10.1159/000525008. eCollection 2022 May-Aug. Case Rep Dermatol. 2022. PMID: 35950146 Free PMC article.
-
A Diagnostically Challenging Case of De Novo Febrile Ulceronecrotic Mucha-Habermann Disease with Fatal Pulmonary Involvement: A Case Report.Case Rep Dermatol. 2023 Jan 18;15(1):17-21. doi: 10.1159/000528500. eCollection 2023 Jan-Apr. Case Rep Dermatol. 2023. PMID: 36686043 Free PMC article.
-
A Fatal Case of Febrile Ulceronecrotic Mucha-Habermann Disease which Presenting as Toxic Epidermal Necrolysis.Indian J Dermatol. 2017 Nov-Dec;62(6):675. doi: 10.4103/ijd.IJD_631_16. Indian J Dermatol. 2017. PMID: 29263553 Free PMC article.
-
Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: A systematic review of therapeutic outcomes and complications.Dermatol Reports. 2022 Nov 21;14(4):9492. doi: 10.4081/dr.2022.9492. eCollection 2022 Nov 21. Dermatol Reports. 2022. PMID: 36483219 Free PMC article.
-
[Febrile ulceronecrotic Mucha-Habermann syndrome].Hautarzt. 2007 Oct;58(10):835-6. doi: 10.1007/s00105-007-1399-5. Hautarzt. 2007. PMID: 17846729 German. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources